Skip to main content

Table 2 Distribution of chemotherapy regimens among the five age groups

From: An age-group analysis on the efficacy of chemotherapy in older adult patients with metastatic biliary tract cancer: a Japanese cancer registry cohort study

Age group

1) 70–74

(n = 63)

2) 75–79

(n = 72)

3) 80–84

(n = 45)

4) 85–89

(n = 22)

4) ≥ 90

(n = 5)

 

n (%)

n (%)

n (%)

n (%)

n (%)

Chemotherapy

     

 Yes

47 (74.6)

43 (59.7)

16 (35.6)

9 (40.9)

1 (20.0)

 No

16 (25.4)

29 (40.3)

29 (64.4)

13 (59.1)

4 (80.0)

1st line

  

 GC

28 (59.6)

26 (60.5)

7 (43.8)

2 (22.2)

0 (0.0)

 GS

1 (2.1)

1 (2.3)

0 (0.0)

0 (0.0)

0 (0.0)

 GEM

13 (27.7)

11 (25.6)

6 (37.5)

4 (44.4)

1 (100)

 S-1

5 (10.6)

5 (11.6)

3 (18.7)

3 (33.3)

0 (0.0)

  1. GC, gemcitabine plus cisplatin; GS, gemcitabine plus S-1
  2. GEM, gemcitabine; S-1, oral fluoropyrimidine